Management of patients with advanced breast cancer.
Although patients with recurrent breast cancer are not curable with presently available treatments, the duration of survival after the development of metastases has increased to about three years. This has been due to optimal supportive care as well as the use of endocrine therapy, chemotherapy and radiotherapy for symptom control. With these methods quality of life can usually be maintained for much of this period.
Mackintosh
J F
JF
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000523:psychology / Q000532:radiotherapy; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008535:Megestrol / Q000627:therapeutic use*
D008535:Megestrol; D008525:Medroxyprogesterone